<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-XEMLVV8I/dc9daeb7-2321-4ec1-89c0-3e36dc4eef8c/PDF"><dcterms:extent>360 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-XEMLVV8I/e9be5bae-cd1b-4369-92a5-09ce8adba87c/TEXT"><dcterms:extent>12 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-XEMLVV8I"><edm:isNextInSequence rdf:resource="https://www.dlib.si/details/URN:NBN:SI:doc-TRYX277M" /><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>1999</dcterms:issued><dc:creator>Pompe-Kirn, Vera</dc:creator><dc:format xml:lang="sl">letnik:33</dc:format><dc:format xml:lang="sl">str. S14-S19</dc:format><dc:format xml:lang="sl">številka:suppl. 1</dc:format><dc:identifier>COBISSID:10732761</dc:identifier><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-XEMLVV8I</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Croatian Medical Association - Croatian Society of Radiology</dc:publisher><dc:publisher xml:lang="sl">Slovenian Medical Society - Section of Radiology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="sl">epidemiologija</dc:subject><dc:subject xml:lang="sl">Epidemiology</dc:subject><dc:subject xml:lang="sl">Incidence</dc:subject><dc:subject xml:lang="sl">kožne bolezni</dc:subject><dc:subject xml:lang="sl">Melanoma</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dc:subject xml:lang="sl">Skin neoplasms</dc:subject><dc:subject xml:lang="sl">Slovenija</dc:subject><dc:subject xml:lang="sl">Survival rate</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Epidemiološke značilnosti kožnega malignega melanoma v Sloveniji| Epidemiological features of skin malignant melanoma in Slovenia|</dc:title><dc:description xml:lang="sl">Since the year 1980, also in Slovenia the incidence in skin malignant melanomahas been steeply increasing. In the period 1994-1996 an average numberof 82 new cases in men and 93 cases in women was registered. The prediction for th eperiood 2005-2009 has been 147 cases in men and 93 cases in women. In Slovenia, an unfavorably high percentage of advanced (Clark IV and V) stage at diagnosis was registered. Th e most frequently site of skin lesions was trunk (51%) in men, and lower limb (39%) in women. In the period 1973-1993 the five-, and ten-year patient's survival with invasive disease wasgradually improving. For the patients diagnosed in 1991-1993 the observed survival in men was 50,5%, and the relative survival 58,8%, while in women these rates were 62,5% and 68,2% respectively. In patients with a localized tumor the observed survival was 60% and the relative survival 69% in men, while in women the relevant rates were 71% and 76,5%, respectively. It is due to the high percentage of the advanced stages that Slovenia ranked the second-last for men, and the third-last for women, amongst 45 registries from 17 selected, mainly more developed countries</dc:description><dc:description xml:lang="sl">Od leta 1980 dalje incidenca kožnega malignega melanoma strmo narašča tudi v Sloveniji. V letih 1994-1996 je povprečno letno zbolelo že 82 moških in 93 žensk, za leta 2005-2009 pa predvidevamo, da bo povprečno letno zbolelo 147 moških in 160 žensk. Zaenkrat je za Slovenijo značilen izredno visok delež bolezni odkrite v napredovalnem stadiju (Clark IV in V), najpogostejše mesto kožne spremembe je pri moških trup (51%) in pri ženskah spodnje okončine (39%). Pet- in deset-letno preživetje bolnikov z invazijsko boleznijo se je v obdobju 1973-1993 postopoma izboljševalo, vseskozi je bilo pri moških slabše kot pri ženskah, tudi kadar smo opazovali bolnike z omejeno boleznijo ločeno. Za zbolele v letih 1991-1993 je bilo pri moških opazovano prezivetje 50,5% in relativno 58,8% in pri ženskah pa 62,5% opazovano in 68,2% relativno, za bolnike z omejeno boleznnijo pa pri moških 60% oz. 69% in pri ženskah 71% oz. 76,5%. V velikem deležu napredovale bolezni tiči vzrok, da se je v druščini 45registrov raka iz 17 izbranih, pretežno razvitejših držav Evrope, Slovenija po petletnem preživetju za zbolele v letih 1985-1989 uvrstila na predzadnje mesto pri moških in na predpredzadnje pri ženskah</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-XEMLVV8I"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-XEMLVV8I" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-XEMLVV8I/dc9daeb7-2321-4ec1-89c0-3e36dc4eef8c/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Onkološki inštitut Ljubljana</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-XEMLVV8I/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-XEMLVV8I" /></ore:Aggregation></rdf:RDF>